Evonik has more than 32 major production sites in the U.S. and Canada, as well as numerous offices, labs, warehouses and distribution centers, employing about 4,800 people in the region. ... MORE
Evonik is acquiring the Porocel Group for US$210 million to accelerate the growth of its catalysts business. ... MORE
Against the backdrop of the worldwide recession triggered by the Corona pandemic, Evonik is getting through the crisis well. ... MORE
Evonik’s Care Solutions business line has launched TOMADOL® 904, a new multifunctional surfactant for hard surface cleaning applications in North America. ... MORE
Evonik is further expanding its business in the area of additive manufacturing. The specialty chemicals company has opened a new technology center for 3D printing in Austin, Texas. ... MORE
Evonik’s Care Solutions Business Line has launched TOMAKLEEN® G-14, a new solution to replace oxygenated solvents used for industrial and institutional cleaning products in North America. ... MORE
The Plastics Pipe Institute recently named an installation featuring Evonik’s VESTAMID® NRG polyamide 12 as Project of the Year in the PPI Energy Piping Systems Division. ... MORE
Together we rely on the values of diversity, fairness and inclusion and believe it makes us a stronger company.
Together we condemn hatred and discrimination in the workplace and our communities.
Together we support the rights of all individuals to pursue a life free from discrimination regardless of ... MORE
Evonik has successfully closed the acquisition of the US company PeroxyChem for US$640 million after the responsible court in Washington D.C. dismissed the lawsuit filed by the Federal Trade Commission (FTC) to block the acquisition. ... MORE
Due to increasing demand for lightweight construction materials for specialty applications, Evonik Corporation is expanding its production of ROHACELL® high performance rigid, closed-cell foams at its Mobile, Ala., site. ... MORE
Evonik acquires a surface modification technology platform from Interface Biologics to further expand its medical device capabilities. Endexo® platform enhances medical device biocompatibility. ... MORE
A team of over 32,000 people, many of whom can count their tenure in decades. A history of innovation and creativity that stretches back more than 170 years, and continues today. An active presence in 26 countries worldwide. A portfolio of more than 4,000 products. ... MORE
Evonik will be attending the following exhibitions and trade shows in North America in 2020. ... MORE
Evonik is one of the world's leading specialty chemicals companies. The central elements of our strategy for sustained value creation are profitable growth, efficiency and values. ... MORE
